253 related articles for article (PubMed ID: 2862302)
1. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
[TBL] [Abstract][Full Text] [Related]
3. Adrenoceptor blocking and cardiovascular effects of the optical isomers of amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent, and the corresponding desoxy derivative (YM-11133) in rats.
Honda K; Nakagawa C; Inagaki O; Shibasaki M; Takenaka T; Takeda M
Jpn J Pharmacol; 1986 Aug; 41(4):459-66. PubMed ID: 2877109
[TBL] [Abstract][Full Text] [Related]
4. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
Honda K; Takenaka T; Miyata-Osawa A; Terai M
J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
[TBL] [Abstract][Full Text] [Related]
5. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
Riva E; Mennini T; Latini R
Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
[TBL] [Abstract][Full Text] [Related]
6. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats.
Palluk R; Hoefke W
Arch Int Pharmacodyn Ther; 1989; 301():215-27. PubMed ID: 2576194
[TBL] [Abstract][Full Text] [Related]
8. Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
Nakahara H; Nakazawa M; Takeda K; Imai S
Jpn J Pharmacol; 1985 Dec; 39(4):487-92. PubMed ID: 2419613
[TBL] [Abstract][Full Text] [Related]
9. Effects of the R, R-isomer of labetalol, SCH 19927, in isolated tissues and in spontaneously hypertensive rats during a repeated treatment.
Monopoli A; Bamonte F; Forlani A; Ongini E; Parravicini L
Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):256-63. PubMed ID: 6151824
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological effects of amosulalol, a new alpha- and beta-adrenoceptor blocker, in isolated rabbit papillary muscles.
Tohse N; Nakaya H; Kanno M
Eur J Pharmacol; 1986 Jun; 125(3):411-9. PubMed ID: 2874042
[TBL] [Abstract][Full Text] [Related]
11. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
Drew GM; Hilditch A; Levy GP
Clin Exp Hypertens (1978); 1979; 1(5):597-611. PubMed ID: 42517
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Antonaccio MJ; High J; DeForrest JM; Sybertz E
J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological basis for antihypertensive effects of intravenous labetalol.
Richards DA; Prichard BN; Boakes AJ; Tuckman J; Knight EJ
Br Heart J; 1977 Jan; 39(1):99-106. PubMed ID: 12778
[TBL] [Abstract][Full Text] [Related]
14. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
15. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
Richards DA; Tuckman J; Prichard BN
Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic receptor effects and antihypertensive actions of beta-adrenoceptor-blocking agents with ancillary properties.
Imai S; Nakahara H; Nakazawa M; Takeda K
Drugs; 1988; 36 Suppl 6():10-9. PubMed ID: 2908298
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
Hara Y; Nakahara H; Miyagishi A; Nakatani H
Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological properties of (+/-)-4-[2-hydroxy-3-(3-(2-methoxyphenoxy)-2-propylamino)propoxy]-1(2H) -isoquinolinone (N-1518), a new combined alpha- and beta-adrenoceptor blocking drug].
Sugai T
Nihon Yakurigaku Zasshi; 1990 Sep; 96(3):117-27. PubMed ID: 1980255
[TBL] [Abstract][Full Text] [Related]
19. Alpha-adrenoceptor blockade by labetalol during long-term dosing.
Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F
Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864
[TBL] [Abstract][Full Text] [Related]
20. Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals.
Kennedy I; Levy GP
Br J Pharmacol; 1975 Apr; 53(4):585-92. PubMed ID: 238705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
